{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2024-01-29&min-date=2024-04-12&min-answer.questionFirstAnswered.=2019-05-17T09%3A24%3A23.933Z&tablingMemberConstituency=Stroud", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-answer.dateOfAnswer=2024-01-29&min-date=2024-04-12&min-answer.questionFirstAnswered.=2019-05-17T09%3A24%3A23.933Z&tablingMemberConstituency=Stroud", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2024-01-29&min-date=2024-04-12&min-answer.questionFirstAnswered.=2019-05-17T09%3A24%3A23.933Z&tablingMemberConstituency=Stroud&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2024-01-29&_page=0&min-date=2024-04-12&min-answer.questionFirstAnswered.=2019-05-17T09%3A24%3A23.933Z&tablingMemberConstituency=Stroud", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2024-01-29&min-date=2024-04-12&min-answer.questionFirstAnswered.=2019-05-17T09%3A24%3A23.933Z&tablingMemberConstituency=Stroud", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2024-01-29&min-date=2024-04-12&min-answer.questionFirstAnswered.=2019-05-17T09%3A24%3A23.933Z&tablingMemberConstituency=Stroud", "items" : [{"_about" : "http://data.parliament.uk/resources/1714864", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1714864/answer", "answerText" : {"_value" : "

Notifiable diseases, listed under schedule 1 of the Health Protection (Notification) Regulations 2010, are kept under review by the Department and the UK Health Security Agency (UKHSA). The Government published a public consultation between 12 July and 15 November 2023, seeking views on proposed amendments to the regulations, including adding diseases to schedule 1 to make them notifiable.<\/p>

Adding Group B Streptococcal (GBS) Infection to schedule 1 was not included in the consultation proposals, but a small number of respondents suggested it could be suitable for inclusion. A summary of responses to the consultation has been published. The Department and the UKHSA are considering the consultation responses, and confirmation of any changes to the regulations will be published in due course.<\/p>

To increase awareness and understanding of GBS, NHS England published a revised Core Competency Framework in May 2023, which covers the mandated training for all maternity services, which now includes GBS. Undertaking this training will enable midwives and doctors to be better informed when speaking to families about the risk of GBS in labour. The Core Competency Framework is incentivised through the maternity incentive scheme administrated by NHS Resolution.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2024-05-07", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-07T16:41:43.077Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-04-30", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Streptococcus: Babies"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of making Group B Strep a notifiable disease on the (a) prevention and (b) treatment of this infection in newborns.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4847", "label" : {"_value" : "Biography information for Siobhan Baillie"} } , "tablingMemberConstituency" : {"_value" : "Stroud"} , "tablingMemberPrinted" : [{"_value" : "Siobhan Baillie"} ], "uin" : "24343"} , {"_about" : "http://data.parliament.uk/resources/1714865", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1714865/answer", "answerText" : {"_value" : "

National surveillance systems, established and managed by the UK Health Security Agency (UKHSA), are used to monitor trends, characteristics, and outcomes of Group B Streptococcus (GBS) infection, vital to prevention efforts. These include the reporting of cases diagnosed in local microbiology laboratories, and the submission of clinical isolates to the national reference laboratory. Analyses based on this surveillance is published in annual reports.<\/p>

The UKHSA has jointly co-ordinated periods of enhanced surveillance with academic and public health collaborators, allowing greater understanding of risk factors and outcomes of infection, vital in identifying opportunities for prevention. Data generated through laboratory surveillance is utilised to assess the impact of prevention efforts.<\/p>

The list of notifiable diseases is kept under review by the Department, with UKHSA involvement. Should GBS be added to the list of notifiable diseases, the means to assess the impact of this change on surveillance data will be considered.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2024-05-07", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-07T16:37:36.45Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-04-30", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Streptococcus: Disease Control"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what systems her Department has in place to (a) track and (b) report cases of Group B Strep infection; and if she will make an assessment of the potential impact of making Group B Strep a notifiable disease on those systems.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4847", "label" : {"_value" : "Biography information for Siobhan Baillie"} } , "tablingMemberConstituency" : {"_value" : "Stroud"} , "tablingMemberPrinted" : [{"_value" : "Siobhan Baillie"} ], "uin" : "24344"} , {"_about" : "http://data.parliament.uk/resources/1700999", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1700999/answer", "answerText" : {"_value" : "

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC\u2019s recommendations and will respond substantively in due course. Bowel mesh, also known as rectopexy mesh, did not fall within the definition of pelvic organ prolapse that the PSC investigated for her report.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2024-04-19", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "21867"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-04-19T13:23:37.123Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-04-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Sodium Valproate: Compensation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what her Department's timescales are for responding to The Hughes Report, published by the Patient Safety Commissioner on 7 February 2024.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4847", "label" : {"_value" : "Biography information for Siobhan Baillie"} } , "tablingMemberConstituency" : {"_value" : "Stroud"} , "tablingMemberPrinted" : [{"_value" : "Siobhan Baillie"} ], "uin" : "21866"} , {"_about" : "http://data.parliament.uk/resources/1701000", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1701000/answer", "answerText" : {"_value" : "

The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC\u2019s recommendations and will respond substantively in due course. Bowel mesh, also known as rectopexy mesh, did not fall within the definition of pelvic organ prolapse that the PSC investigated for her report.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2024-04-19", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "21866"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-04-19T13:23:37.183Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-04-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Surgical Mesh Implants: Compensation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to The Hughes Report, published by the Patient Safety Commissioner on 7 February 2024, if she will ensure that people impacted by bowel mesh are eligible for financial redress.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4847", "label" : {"_value" : "Biography information for Siobhan Baillie"} } , "tablingMemberConstituency" : {"_value" : "Stroud"} , "tablingMemberPrinted" : [{"_value" : "Siobhan Baillie"} ], "uin" : "21867"} , {"_about" : "http://data.parliament.uk/resources/1700370", "AnsweringBody" : [{"_value" : "Cabinet Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1700370/answer", "answerText" : {"_value" : "

Ministerial colleagues and I, as well as officials in the Cabinet Office and relevant other Government Departments, are working closely to ensure effective design and implementation of the Government response to Inquiry, with regular meetings and engagement across Whitehall.<\/p>

<\/strong><\/p>

The Government is committed to responding to the recommendations made by Sir Brian Langstaff in full, after the publication of the final report. The Government has appointed an expert group to provide advice on recommendations regarding compensation, and we are bringing forward amendments to the Victims and Prisoners Bill at Report Stage in the Other Place to speed up the Government response to the Inquiry.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4051", "label" : {"_value" : "Biography information for John Glen"} } , "answeringMemberConstituency" : {"_value" : "Salisbury"} , "answeringMemberPrinted" : {"_value" : "John Glen"} , "dateOfAnswer" : {"_value" : "2024-04-17", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "21123"} , {"_value" : "21258"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-04-17T15:48:53.657Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "53"} , "answeringDeptShortName" : {"_value" : "Cabinet Office"} , "answeringDeptSortName" : {"_value" : "Cabinet Office"} , "date" : {"_value" : "2024-04-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Blood: Contamination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Minister for the Cabinet Office, what steps he is taking to ensure coordination across Government departments on the efficient implementation of the full infected blood compensation scheme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4847", "label" : {"_value" : "Biography information for Siobhan Baillie"} } , "tablingMemberConstituency" : {"_value" : "Stroud"} , "tablingMemberPrinted" : [{"_value" : "Siobhan Baillie"} ], "uin" : "21257"} , {"_about" : "http://data.parliament.uk/resources/1700371", "AnsweringBody" : [{"_value" : "Cabinet Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1700371/answer", "answerText" : {"_value" : "

Ministerial colleagues and I, as well as officials in the Cabinet Office and relevant other Government Departments, are working closely to ensure effective design and implementation of the Government response to Inquiry, with regular meetings and engagement across Whitehall.<\/p>

<\/strong><\/p>

The Government is committed to responding to the recommendations made by Sir Brian Langstaff in full, after the publication of the final report. The Government has appointed an expert group to provide advice on recommendations regarding compensation, and we are bringing forward amendments to the Victims and Prisoners Bill at Report Stage in the Other Place to speed up the Government response to the Inquiry.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4051", "label" : {"_value" : "Biography information for John Glen"} } , "answeringMemberConstituency" : {"_value" : "Salisbury"} , "answeringMemberPrinted" : {"_value" : "John Glen"} , "dateOfAnswer" : {"_value" : "2024-04-17", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "21123"} , {"_value" : "21257"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-04-17T15:48:53.703Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "53"} , "answeringDeptShortName" : {"_value" : "Cabinet Office"} , "answeringDeptSortName" : {"_value" : "Cabinet Office"} , "date" : {"_value" : "2024-04-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Blood: Contamination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Minister for the Cabinet Office, what preparations his Department is making for the roll-out of the infected blood compensation scheme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4847", "label" : {"_value" : "Biography information for Siobhan Baillie"} } , "tablingMemberConstituency" : {"_value" : "Stroud"} , "tablingMemberPrinted" : [{"_value" : "Siobhan Baillie"} ], "uin" : "21258"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 6, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }